Dr. Vitti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Bolton Pl
Port Chester, NY 10573Phone+1 914-471-1485
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Ophthalmology, 1989 - 1992
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1988 - 1989
- State University of New York Downstate Medical Center College of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 1989 - 2025
Clinical Trials
- Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Start of enrollment: 2001 Jun 01
- Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.Charles C Wykoff, Diana V Do, W Lloyd Clark, David S Boyer, Dilsher S Dhoot
Ophthalmology. Retina. 2024-10-16 - 1 citationsOcular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR: Post Hoc Analysis of the PANORAMA Trial.Charles C Wykoff, Diana V Do, Roger A Goldberg, Dilsher S Dhoot, Jennifer I Lim
Ophthalmology. Retina. 2023-10-27 - 19 citationsEffect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.Charles C Wykoff, David M Brown, Kimberly Reed, Alyson J Berliner, Adam T Gerstenblith
JAMA Ophthalmology. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: